Cargando…
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium
BACKGROUND: Pseudomonas aeruginosa airway infections are a major cause of morbidity and mortality in patients with cystic fibrosis (CF). Azithromycin improves the related clinical outcomes, but its mechanisms of action remain poorly understood. We tested the hypothesis that azithromycin downregulate...
Autores principales: | Leal, Teresinha, Bergamini, Gabriella, Huaux, François, Panin, Nadtha, Noel, Sabrina, Dhooghe, Barbara, Haaf, Jeremy B., Mauri, Pierluigi, Motta, Sara, Di Silvestre, Dario, Melotti, Paola, Sorio, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108761/ https://www.ncbi.nlm.nih.gov/pubmed/27895643 http://dx.doi.org/10.3389/fimmu.2016.00499 |
Ejemplares similares
-
Dysregulated Proinflammatory and Fibrogenic Phenotype of Fibroblasts in Cystic Fibrosis
por: Huaux, François, et al.
Publicado: (2013) -
Vardenafil increases intracellular accumulation of the most prevalent mutant cystic fibrosis transmembrane conductance regulator (CTFR) in human bronchial epithelial cells
por: Dhooghe, Barbara, et al.
Publicado: (2020) -
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin
por: Stellari, Fabio, et al.
Publicado: (2015) -
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice
por: Sandri, Angela, et al.
Publicado: (2018) -
PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis
por: Noel, Sabrina, et al.
Publicado: (2012)